Roundhill Investments - GLP-1 & Weight Loss ETF
Not enough financial coverage to compute a composite score for OZEM. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.roundhillinvestments.com/etf/ozem
Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
- IPO
- 2024
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $39.22M
- Div Yield
- 1.34%
Performance & Tape
- 52W High
- $37.15
- 52W Low
- $23.22
- 50D MA
- $31.24
- 200D MA
- $30.97
- Beta
- 0.44
- Avg Volume
- 22.09K
Get TickerSpark's AI analysis on OZEM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our OZEM Coverage
We haven't published any research on OZEM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OZEM Report →